Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Libtayo (cemiplimab-rwlc) for the Treatment of CSCC

Libtayo is the first and only treatment approved for the treatment of advanced CSCC. Image courtesy of Regeneron and Sanofi.

  • Libtayo
  • Libtayo
  • Libtayo

Go Top